Our mission is to prevent cancer mortality through earlier detection and closer monitoring of disease.
Location: Sweden, Stockholm
Employees: 11-50
Total raised: $27.63M
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | Bonnier Ca... | bonniercap... |
| - | Navigare V... | navigareve... |
| - | Norrsken V... | norrsken.v... |
| - | Industrifo... | industrifo... |
| - | SUP46 | SUP46.com/ |
| - | Chalmers V... | chalmersve... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.06.2022 | Series A | $21M | - |
| 23.01.2020 | Seed | $6.63M | - |
Mentions in press and media 20
| Date | Title | Description |
| 29.09.2025 | Scaling lessons for tech companies: Quotes from successful European deep tech founders | If you think attracting investment is tough for a regular startup, imagine for a moment what it’s like for a deep tech founder. You’ve developed a groundbreaking technology, often the result of years of R&D and lab work. Now you’re thru... |
| 29.05.2025 | New Frontiers in Cancer Treatment: Elacestrant and Kidney Cancer Monitoring | In the relentless battle against cancer, innovation is the sword and shield. Two recent developments shine a light on this ongoing fight: the promising data surrounding elacestrant for breast cancer and the completion of a significant kidne... |
| 27.05.2025 | Elypta reaches Study End in Largest Kidney Cancer Recurrence Monitoring Study | Elypta reaches Study End in Largest Kidney Cancer Recurrence Monitoring Study Tue, May 27, 2025 07:30 CET Report this content Solna, Sweden, 27 May 2025 — Swedish molecular diagnostics company Elypta has successfully completed patient follo... |
| 19.05.2025 | Elypta a main partner in groundbreaking pan-European hereditary multi-cancer screening project | Elypta a main partner in groundbreaking pan-European hereditary multi-cancer screening project Mon, May 19, 2025 08:00 CET Report this content Solna, Sweden, 19 May 2025 — Swedish molecular diagnostics company Elypta announced its role as a... |
| 07.04.2025 | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors Mon, Apr 07, 2025 08:30 CET Report this content Stockholm, Sweden, April 7, 2025. Elypta, the Swedish company pioneering metabolism-based early cancer detec... |
| 24.03.2025 | Elypta’s urine test shows game-changing potential in kidney cancer follow-up | Elypta’s urine test shows game-changing potential in kidney cancer follow-up Mon, Mar 24, 2025 07:00 CET Report this content Stockholm – March 24, 2025 – Elypta, the Swedish company pioneering metabolism-based cancer diagnostics, is proud t... |
| 30.10.2024 | Swedish Cancer Detection Company Elypta Joins European Innovation Council Scaling Club – could it Become a Unicorn? | Swedish Cancer Detection Company Elypta Joins European Innovation Council Scaling Club – could it Become a Unicorn? Wed, Oct 30, 2024 08:30 CET Report this content October 30, 2024 Solna, Sweden. Swedish life science company Elypta is delig... |
| 07.05.2024 | Elypta, a Swedish company using metabolism-based liquid biopsy for early detection of cancer, appoints Dr. Eva Pisa to Board of Directors | Elypta, a Swedish company using metabolism-based liquid biopsy for early detection of cancer, appoints Dr. Eva Pisa to Board of Directors Tue, May 07, 2024 08:30 CET Report this content Stockholm, May 7, 2024: Elypta, a Swedish cancer detec... |
| 08.04.2024 | Elypta interim study LEVANTIS-0087A results show glycosaminoglycan's potential to predict the risk of developing any cancer with a simple urine test | Elypta interim study LEVANTIS-0087A results show glycosaminoglycan's potential to predict the risk of developing any cancer with a simple urine test Mon, Apr 08, 2024 09:00 CET Report this content The results will be presented at the 2024 A... |
| 06.07.2023 | Elypta - Multi Cancer Early Detection Company Developing First GAGome -Based Tests - Receives ISO 13485:2016 Quality Certification | Elypta - Multi Cancer Early Detection Company Developing First GAGome -Based Tests - Receives ISO 13485:2016 Quality Certification Thu, Jul 06, 2023 08:00 CET Report this content Stockholm, July 6, 2023: Swedish early cancer detection compa... |
Show more